Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Clot Management devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. GlobalData uses proprietary data and analytics to provide a comprehensive report on the clot management devices market in Israel. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the clot management devices market in Israel was AngioDynamics followed by Argon Medical Devices, Becton Dickinson and Co, Boston Scientific, Cook Medical, Edwards Lifesciences, Koninklijke Philips, LeMaitre Vascular, Medtronic, Merit Medical Systems, Penumbra, Teleflex and Terumo.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
The Clot Management Device is used in a routine procedure while performing Percutaneous Coronary Intervention and to treat potentially life-threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This category includes Inferior Vena Cava Filter (IVCF), Embolectomy Balloon Catheters, Manual Aspiration Thrombectomy devices, Rotational Thrombectomy devices, Thrombectomy Systems (Catheters) and CDT Catheters.
The clot management devices market in Israel can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size clot management devices in Israel, buy the report here.